Mankind Pharma enters into agri-tech segment with launch of Mankind Agritech
The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector, it added.
Advertisement
New Delhi: Mankind Pharma has announced the company's entry into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years. The company has set up a new arm Mankind Agritech Pvt Ltd, which will offer a variety of crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators and biologicals, Mankind Pharma said in a statement.
"We are happy to announce our launch in the agritech domain with long-term investment plans, with an initial (Rs) 150 to (Rs) 200 crore capex infusion in the first two to three years," Mankind Pharma Managing Director and Vice-Chairman Rajeev Juneja said.
Asserting that technology is playing a crucial role in ensuring the growth of the agriculture sector in India, he said, "Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools they would be in a position to make an informed decision of using input and right technology".
The new vertical will be headed by Indian agrochemical industry veteran Partha Sengupta, who was the national marketing head and part of the senior leadership team at Dhanuka Agritech Ltd, overseeing marketing operations in India, Bangladesh and Nepal, the company said.
The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector, it added.
Read also: Mankind Pharma donates Rs 5 lakh to the family of Indian medical student who died in Ukraine
Mankind Pharma is the fourth largest pharmaceutical company in India headquartered in New Delhi, India. Its products range from Pharma, OTC and FMCG brands like Manforce Condoms, Unwanted 72, Prega News, Gas-O-Fast, Health OK Tablets, Acnestar Gel, Betakind Gargle and many others.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.